Xometry director to sell 5,000 shares via UBS

Xometry, Inc. (XMTR) has a notice of proposed sale of securities filed under Rule 144 for shares of its Class A Common Stock.

Rhea-AI Filing Summary

Xometry, Inc. (XMTR) has a notice of proposed sale of securities filed under Rule 144 for shares of its Class A Common Stock. Director Katherine Weymouth, through UBS Financial Services Inc., indicates an intention to sell 5,000 shares of Class A Common Stock of Xometry.

The notice also lists a prior transaction during the past three months, showing a sale involving 5,000 shares of Xometry stock on 08/28/2026, with an associated value of 471500. The planned sale references a cashless exercise of options and trading on NASDAQ.

Key Figures

Shares proposed to be sold: 5,000 shares of Class A Common Stock Shares sold during past 3 months: 5,000 shares Value associated with past 3 months sale: 471500 +1 more

4 metrics

Shares proposed to be sold 5,000 shares of Class A Common Stock Planned sale by Katherine Weymouth under Rule 144

Shares sold during past 3 months 5,000 shares Transaction listed on 08/28/2026 in the past 3 months section

Value associated with past 3 months sale 471500 Amount shown beside 5,000 shares sold on 08/28/2026

Planned transaction date 08/31/2026 Date shown for securities to be sold and related entries

Key Terms

Rule 144, Cashless Exercise, attorney-in-fact, Class A Common, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Cashless Exercise financial

"5000 | 08/31/2026 | Cashless Exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

attorney-in-fact regulatory

"for UBS Financial Services Inc, as attorney-in-fact for Katherine"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Class A Common financial

"144: Securities Information Class A Common | UBS Financial Services Inc"

NQO financial

"Class A Common | 08/31/2026 | NQO | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for XMTR disclose about planned share sales?

The Form 144 notice discloses that Katherine Weymouth, a director of Xometry, plans to sell 5,000 shares of the company’s Class A Common Stock through UBS Financial Services Inc. under Rule 144, with trading expected on NASDAQ.

Who is the insider involved in the XMTR Form 144 filing?

The insider is Katherine Weymouth, identified as a Director of Xometry, Inc. The filing covers her proposed sale of Xometry Class A Common Stock under Rule 144 and notes that UBS Financial Services Inc. is the broker handling the transaction.

How many XMTR shares are proposed to be sold under this Form 144?

The Form 144 filing reports an intention to sell 5,000 shares of Xometry, Inc. Class A Common Stock. This amount appears in both the securities information and the securities-to-be-sold sections of the notice.

What prior XMTR share sales by the filer are disclosed in the last three months?

The filing lists a transaction during the past three months showing 5,000 shares of Xometry stock associated with 471500 on 08/28/2026, in the section describing securities sold during the past three months.

What transaction method is indicated for the XMTR shares in the Form 144?

The Form 144 notes that the 5,000 shares of Xometry Class A Common Stock are tied to a cashless exercise of options, with an entry dated 08/31/2026 in the securities-to-be-sold section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:02 PM EDT Accepted by SEC EDGAR 08/31/2026 - 04:01 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001501808
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Xometry Inc.
SEC File Number	001-40546
Address of Issuer	6116 Executive Blvd Suite 800 Rockville MARYLAND 20852
Phone	240-252-1138
Name of Person for Whose Account the Securities are To Be Sold	Katherine Weymouth
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	5000	476150	55848262	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	08/31/2026	NQO	Issuer			5000	08/31/2026	Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Katherine Weymouth 3752 Oliver Street, NW Washington DC 20015	Xometry	08/28/2026	5000	471500

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Katherine Weymouth
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)